Wednesday, April 12, 2023 5:19:11 PM
FeMike,
Linda’s husband is already a billionaire and Linda in her own right will likely be within the next 2 years based only on what she gains from NWBO holdings. Her CDMOs and salary over the years wouldn’t have helped get her there so quickly alone especially if promoting failed science. Myself and others would have been out long ago if that had been the case. It’s not failed science she brought forward and she now has a lot to gain from the shares she owns but was and is smart enough to never have put herself at risk of being a financial looser with NWBO for long. Only her initial investment would have been able to do that and even though it looked like NWBO was financially vulnerable all these years Linda always had access to financing. She just always took financing that left the most risk being held by others because that financing was available. Many investors have not understood this.
Linda is part of an elite group of folks in biotech that is bringing a JAMA Oncology backed, statistically significant paradigm shifting platform technology winner to the MHRA, FDA and other regulators on the first go round. I’d say that is good logic for saying “LP is a shareholder too. Years ago, she loaned her own money to fund clinical research into DCVax-L”. Best wishes.
Linda’s husband is already a billionaire and Linda in her own right will likely be within the next 2 years based only on what she gains from NWBO holdings. Her CDMOs and salary over the years wouldn’t have helped get her there so quickly alone especially if promoting failed science. Myself and others would have been out long ago if that had been the case. It’s not failed science she brought forward and she now has a lot to gain from the shares she owns but was and is smart enough to never have put herself at risk of being a financial looser with NWBO for long. Only her initial investment would have been able to do that and even though it looked like NWBO was financially vulnerable all these years Linda always had access to financing. She just always took financing that left the most risk being held by others because that financing was available. Many investors have not understood this.
Linda is part of an elite group of folks in biotech that is bringing a JAMA Oncology backed, statistically significant paradigm shifting platform technology winner to the MHRA, FDA and other regulators on the first go round. I’d say that is good logic for saying “LP is a shareholder too. Years ago, she loaned her own money to fund clinical research into DCVax-L”. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
